Clean Science & Technology
Stock Snapshot
Price Performance
Vista Outlook
Basis of our Recommendation
Clean Science & Technology Limited (CSTL) is strategically pivoting towards high-value specialty chemicals, particularly in the HALS segment, which is expected to drive revenue growth. Management's focus on operational discipline and backward integration through the CFCL facility enhances cost leadership, positioning CSTL favorably against competitors. Despite facing macroeconomic challenges, including raw material price volatility and geopolitical tensions, the company is optimistic about achieving a targeted revenue CAGR of 18% over FY26-28. Vista's financial outlook reflects this optimism, with expectations of improving margins and stable revenue recovery. The anticipated commissioning of the Performance Chemicals 2 plant and strategic partnerships are key catalysts for growth. However, investors should remain vigilant regarding execution risks and margin pressures from commodity chemicals. Overall, CSTL's commitment to R&D and sustainable practices underpins its long-term growth potential, while the current valuation aligns with intrinsic value, suggesting a fair investment opportunity with an expected upside of 7.2%. Over the next 12-24 months, the company must navigate execution challenges while capitalizing on its strategic initiatives to enhance market share and profitability
Why We Like This Stock
- Strategic pivot towards high-value specialty chemicals, particularly in the HALS segment, is expected to drive significant revenue growth
- Management's focus on operational discipline and backward integration enhances cost leadership and competitive positioning
- The anticipated commissioning of the Performance Chemicals 2 plant and strategic partnerships are key growth catalysts
Things To Watch Out For
- Raw material price volatility and geopolitical tensions pose risks to profitability and operational efficiency
- Execution challenges related to capacity expansion and product launches could impact revenue realization
- Margin pressures from commodity chemicals and competitive pricing may hinder overall profitability
Key Parameters
Financial Snapshot
View Technicals Analysis →| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 791 | 967 | 957 | 1,015 | 1,098 |
| Profit Before Tax (Cr.) | 323 | 357 | 310 | 330 | 357 |
| PBT Margin | 40.8% | 36.9% | 32.4% | 32.5% | 32.5% |
| Net Profit (Cr.) | 248 | 260 | 222 | 235 | 254 |
| Earnings Per Share | 23.3 | 24.4 | 20.8 | 22.1 | 23.9 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| IDBI Capital | ▲ Buy | 951 | 20-Aug-2026 |
| Motilal Oswal | ► Neutral | 790 | 03-Aug-2026 |
| Prabhudas Liladhar | ► Hold | 745 | 03-Aug-2026 |
Company Overview
Show Company Profile
Clean Science and Technology Limited, together with its subsidiaries, manufactures fine and specialty chemicals in India, China, the United States, Europe, and internationally. It operates through Performance Chemicals, FMCG Chemicals, and Pharma & Agro Intermediates segments. The company offers performance chemicals, including monomethyl ether of hydroquinone, butylated hydroxy anisole, ascorbyl palmitate, tertiary butyl hydroquinone, hydroquinone, hindered amine light stabilisers, catechol, and butylated hydroxytoluene, as well as clean antiOX 962, 4-oxo tempo, 4-butoxy tempo, clean light stab 770, 4-hydroxy tempo, and dimethyl sebacate. It also provides FMCG chemicals, such as 4-methoxy acetophenone, anisole, guaiacol, butylated hydroxy anisole, l-ascorbyl palmitate, para di-methoxy benzene, and ortho methoxy toluene. In addition, the company offers pharmaceutical and agro intermediates, which includes dicyclohexyl carbodiimide, veratrole, DHDT, para benzoquinone, para di-methoxy benzene, anisole, and ortho methoxy toluene. It serves acrylic monomers and polymers; animal nutrition and feed; coatings, resins, paints, and inks; cosmetic and personal care; electronics and electronic chemicals; edible oils; flavors and fragrances; food and beverages; fuel, lubricants, and industrial fluids; nutraceuticals and dietary supplements; petrochemicals; peptide and fine chemicals synthesis; pharmaceuticals intermediates; plastics; rubber and elastomers; light/UV stabilizers; and water treatment industries. The company was incorporated in 2003 and is headquartered in Pune, India.